Literature DB >> 10453815

Body mass index and colon cancer in a national sample of adult US men and women.

E S Ford1.   

Abstract

The evidence supporting obesity as a risk factor for colon cancer remains inconclusive, especially among women. The author studied the association between obesity and colon cancer in a nationally representative cohort of men and women aged 25-74 years who participated in the First National Health and Nutrition Examination Survey from 1971 to 1975 and were subsequently followed up through 1992. Among the 13,420 persons included in the analytic sample, 222 incident cases of colon cancer were identified. Height and weight were measured during the baseline examination. Compared with participants whose body mass index was less than 22 kg/m2, the hazard ratios were 1.79 (95% confidence interval (CI): 0.87, 3.71), 1.86 (95% CI: 0.86, 4.03), 2.47 (95% CI: 1.14, 5.32), 3.72 (95% CI: 1.68, 8.22), and 2.79 (95% CI: 1.22, 6.35) for participants with a body mass index of 22-<24 kg/m2, 24-<26 kg/m2, 26-<28 kg/m2, 28-<30 kg/m2, and > or = 30 kg/m2, respectively. The hazard ratios were similar for men and women. Subscapular skinfold thickness, but not triceps skinfold thickness, was positively associated with colon cancer incidence among men but not women, after adjustment for body mass index and other possible confounders. These results strongly support the hypothesis that excess body weight is a risk factor for colon cancer among both men and women.

Entities:  

Mesh:

Year:  1999        PMID: 10453815     DOI: 10.1093/oxfordjournals.aje.a010018

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

1.  Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative.

Authors:  Michael S Simon; Cynthia A Thomson; Erin Pettijohn; Ikuko Kato; Rebecca J Rodabough; Dorothy Lane; F Allan Hubbell; Mary Jo O'Sullivan; Lucille Adams-Campbell; Charles P Mouton; Judith Abrams; Rowan T Chlebowski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

Review 2.  Colorectal cancer disparities: issues, controversies and solutions.

Authors:  Venkata S Tammana; Adeyinka O Laiyemo
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

3.  Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Su-Chun Cheng; Tianxi Cai; Andrew Cagan; Vivian S Gainer; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-07       Impact factor: 11.382

4.  Colorectal cancer screening among obese versus non-obese patients in primary care practices.

Authors:  Jeanne M Ferrante; Pamela Ohman-Strickland; Shawna V Hudson; Karissa A Hahn; John G Scott; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2006-10-25

5.  Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.

Authors:  Frank A Sinicrope; Nathan R Foster; Harry H Yoon; Thomas C Smyrk; George P Kim; Carmen J Allegra; Greg Yothers; Daniel A Nikcevich; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

6.  Obesity is an independent prognostic variable in colon cancer survivors.

Authors:  Frank A Sinicrope; Nathan R Foster; Daniel J Sargent; Michael J O'Connell; Cathryn Rankin
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

7.  Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population.

Authors:  Benjamin Stein; Joseph C Anderson; Ramona Rajapakse; Zvi A Alpern; Catherine R Messina; Grace Walker
Journal:  Dig Dis Sci       Date:  2010-01-29       Impact factor: 3.199

8.  Diet induced obesity increases the risk of colonic tumorigenesis in mice.

Authors:  Angelos K Sikalidis; Mark D Fitch; Sharon E Fleming
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

9.  Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.

Authors:  Jairam Vanamala; Lavanya Reddivari; Sridhar Radhakrishnan; Chris Tarver
Journal:  BMC Cancer       Date:  2010-05-26       Impact factor: 4.430

10.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.